[Pharmacokinetics of sisomicin during hemosorption and hemodialysis]. 1985

A A Firsov, and O S Treskina, and L V Umnova, and V L Cherniakov, and O N Vetchinnikova

The effect of hemosorption and hemodialysis on the pharmacokinetics of sisomicin was studied in 17 patients with acute and chronic renal insufficiency. The value of the antibiotic extraction coefficient in hemosorption was almost 2 times higher than that in hemodialysis. In patients on hemosorption, extracorporeal elimination of the antibiotic was of the saturation nature. It was characterized by systematic diminishing of the extraction coefficient, while in patients on hemodialysis, it did not depend on the time (the value of the extraction coefficient was constant). In this connection it is recommended that the rate of diminishing of the extraction coefficient in hemosorption be estimated. Since sisomicin is rapidly absorbed by the column it is not advisable to administer sisomicin to patients before hemosorption.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006464 Hemoperfusion Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose). Hemosorption,Hemoperfusions,Hemosorptions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012853 Sisomicin Antibiotic produced by Micromonospora inyoensis. It is closely related to gentamicin C1A, one of the components of the gentamicin complex (GENTAMICINS). Sisomycin,Sissomicin,4,5-Dehydrogentamicin,Antibiotic 6640,Extramycin,Pathomycin,Rickamicin,Sch-13475,Siseptin,Sisomicin Sulfate,Sisomicin Sulfate (2:5) Salt,Sizomycin,4,5 Dehydrogentamicin,Sch 13475,Sch13475
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D058186 Acute Kidney Injury Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. Acute Kidney Failure,Acute Kidney Insufficiency,Acute Renal Failure,Acute Renal Injury,Acute Renal Insufficiency,Kidney Failure, Acute,Kidney Insufficiency, Acute,Renal Failure, Acute,Renal Insufficiency, Acute,Acute Kidney Failures,Acute Kidney Injuries,Acute Kidney Insufficiencies,Acute Renal Failures,Acute Renal Injuries,Acute Renal Insufficiencies,Kidney Failures, Acute,Kidney Injuries, Acute,Kidney Injury, Acute,Kidney Insufficiencies, Acute,Renal Failures, Acute,Renal Injuries, Acute,Renal Injury, Acute,Renal Insufficiencies, Acute

Related Publications

A A Firsov, and O S Treskina, and L V Umnova, and V L Cherniakov, and O N Vetchinnikova
May 1985, Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology,
A A Firsov, and O S Treskina, and L V Umnova, and V L Cherniakov, and O N Vetchinnikova
April 1978, International journal of clinical pharmacology and biopharmacy,
A A Firsov, and O S Treskina, and L V Umnova, and V L Cherniakov, and O N Vetchinnikova
January 1982, Transactions - American Society for Artificial Internal Organs,
A A Firsov, and O S Treskina, and L V Umnova, and V L Cherniakov, and O N Vetchinnikova
November 1989, Therapeutic drug monitoring,
A A Firsov, and O S Treskina, and L V Umnova, and V L Cherniakov, and O N Vetchinnikova
November 1984, Nihon Jinzo Gakkai shi,
A A Firsov, and O S Treskina, and L V Umnova, and V L Cherniakov, and O N Vetchinnikova
April 1981, Antimicrobial agents and chemotherapy,
A A Firsov, and O S Treskina, and L V Umnova, and V L Cherniakov, and O N Vetchinnikova
July 1974, Kidney international,
A A Firsov, and O S Treskina, and L V Umnova, and V L Cherniakov, and O N Vetchinnikova
August 1973, International journal of clinical pharmacology, therapy and toxicology,
A A Firsov, and O S Treskina, and L V Umnova, and V L Cherniakov, and O N Vetchinnikova
January 1977, Chemotherapy,
A A Firsov, and O S Treskina, and L V Umnova, and V L Cherniakov, and O N Vetchinnikova
January 1990, Urologiia i nefrologiia,
Copied contents to your clipboard!